| 10/17/2024 3:54 PM | MorphoSys (1340243) Filer | Form 15-12G | |
| 10/04/2024 3:21 PM | MorphoSys (1340243) Filer | Form S-8 POS | |
| 10/04/2024 3:24 PM | MorphoSys (1340243) Filer | Form S-8 POS | |
| 10/04/2024 3:27 PM | MorphoSys (1340243) Filer | Form S-8 POS | |
| 10/04/2024 3:30 PM | MorphoSys (1340243) Filer | Form S-8 POS | |
| 10/04/2024 3:33 PM | MorphoSys (1340243) Filer | Form S-8 POS | |
| 10/04/2024 3:36 PM | MorphoSys (1340243) Filer | Form S-8 POS | |
| 10/04/2024 3:18 PM | MorphoSys (1340243) Filer | Form S-8 POS | |
| 10/04/2024 3:16 PM | MorphoSys (1340243) Filer | Form POSASR | |
| 08/27/2024 9:14 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 08/15/2024 3:30 PM | MorphoSys (1340243) Subject NOVARTIS AG (1114448) Filed by | Form SC 13D/A | |
Get the Latest News and Ratings for MPSYF and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for MorphoSys and its competitors with MarketBeat's FREE daily newsletter.
|
| 08/13/2024 3:31 PM | MorphoSys (1340243) Subject NOVARTIS AG (1114448) Filed by | Form SC TO-T/A | |
| 08/07/2024 3:51 PM | MorphoSys (1340243) Subject | Form SC 14D9/A | |
| 08/07/2024 3:30 PM | MorphoSys (1340243) Subject NOVARTIS AG (1114448) Filed by | Form SC TO-T/A | |
| 08/05/2024 7:14 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 08/02/2024 3:30 PM | MorphoSys (1340243) Subject NOVARTIS AG (1114448) Filed by | Form SC TO-T/A | |
| 08/01/2024 3:30 PM | MorphoSys (1340243) Subject NOVARTIS AG (1114448) Filed by | Form SC TO-T/A | |
| 07/31/2024 3:30 PM | MorphoSys (1340243) Subject NOVARTIS AG (1114448) Filed by | Form SC TO-T/A | |
| 07/30/2024 3:30 PM | MorphoSys (1340243) Subject NOVARTIS AG (1114448) Filed by | Form SC TO-T/A | |
| 07/29/2024 3:30 PM | MorphoSys (1340243) Subject NOVARTIS AG (1114448) Filed by | Form SC TO-T/A | |
| 07/25/2024 3:30 PM | MorphoSys (1340243) Subject NOVARTIS AG (1114448) Filed by | Form SC TO-T/A | |
| 07/25/2024 3:05 PM | MorphoSys (1340243) Filer | Form 25 Notification of the removal from listing and registration of matured, redeemed or retired securities | |
| 07/18/2024 3:30 PM | MorphoSys (1340243) Subject NOVARTIS AG (1114448) Filed by | Form SC TO-T/A | |
| 07/18/2024 10:25 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 07/12/2024 3:20 PM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 07/11/2024 3:30 PM | MorphoSys (1340243) Subject NOVARTIS AG (1114448) Filed by | Form SC TO-T/A | |
| 07/05/2024 5:48 AM | MorphoSys (1340243) Subject | Form SC 14D9 | |
| 07/05/2024 5:02 AM | MorphoSys (1340243) Subject NOVARTIS AG (1114448) Filed by | Form SC TO-T | |
| 07/02/2024 9:18 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/21/2024 3:30 PM | MorphoSys (1340243) Subject NOVARTIS AG (1114448) Filed by | Form SC 13D/A | |
| 06/21/2024 9:07 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/20/2024 3:41 PM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/20/2024 3:33 PM | MorphoSys (1340243) Subject | Form SC14D9C | |
| 06/20/2024 2:38 PM | MorphoSys (1340243) Subject NOVARTIS AG (1114448) Filed by | Form SC TO-C | |
| 06/17/2024 3:30 PM | MorphoSys (1340243) Subject NOVARTIS AG (1114448) Filed by | Form SC 13D/A | |
| 06/10/2024 3:30 PM | MorphoSys (1340243) Subject NOVARTIS AG (1114448) Filed by | Form SC 13D/A | |
| 06/10/2024 11:06 AM | GOLDMAN SACHS GROUP INC (886982) Filed by MorphoSys (1340243) Subject | Form SC 13G/A | |
| 06/10/2024 10:01 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/06/2024 3:36 PM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/05/2024 9:22 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/04/2024 3:30 PM | MorphoSys (1340243) Subject NOVARTIS AG (1114448) Filed by | Form SC TO-T/A | |
Financial legend: “This is bad, really bad...” (Ad) Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each warning issued before the crisis hit.
Now the founder of Weiss Ratings, the only conflict-free rating agency in America, says he is watching a $3 trillion problem that could trigger a chain reaction across markets and banks. See Martin Weiss's full warning before this risk spreads further |
| 06/04/2024 9:17 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/31/2024 9:17 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/29/2024 9:17 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/28/2024 9:16 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/24/2024 9:13 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/23/2024 1:19 PM | MorphoSys (1340243) Subject | Form SC 14D9/A | |
| 05/23/2024 9:11 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/23/2024 8:04 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/21/2024 9:07 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/17/2024 9:15 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/16/2024 3:43 PM | MorphoSys (1340243) Subject | Form SC 14D9/A | |
| 05/16/2024 3:31 PM | MorphoSys (1340243) Subject NOVARTIS AG (1114448) Filed by | Form SC TO-T/A | |
| 05/16/2024 9:11 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/15/2024 9:09 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/14/2024 9:27 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/13/2024 9:19 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/10/2024 9:31 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/08/2024 9:08 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/07/2024 3:45 PM | MorphoSys (1340243) Subject NOVARTIS AG (1114448) Filed by | Form SC TO-T/A | |
| 05/07/2024 9:24 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/06/2024 3:30 PM | MorphoSys (1340243) Subject NOVARTIS AG (1114448) Filed by | Form SC TO-T/A | |
| 05/06/2024 9:07 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/03/2024 9:29 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/02/2024 3:31 PM | MorphoSys (1340243) Subject NOVARTIS AG (1114448) Filed by | Form SC TO-T/A | |
| 05/02/2024 9:43 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/30/2024 9:07 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/30/2024 7:57 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/29/2024 3:15 PM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/29/2024 9:17 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/26/2024 9:11 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/25/2024 3:30 PM | MorphoSys (1340243) Subject NOVARTIS AG (1114448) Filed by | Form SC TO-T/A | |
| 04/25/2024 9:38 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/24/2024 10:03 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/23/2024 9:14 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/22/2024 9:32 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/19/2024 9:17 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/18/2024 3:31 PM | MorphoSys (1340243) Subject NOVARTIS AG (1114448) Filed by | Form SC TO-T/A | |
| 04/18/2024 1:33 PM | MorphoSys (1340243) Subject NOVARTIS AG (1114448) Filed by | Form SC 13D | |
| 04/18/2024 9:13 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/17/2024 3:49 PM | MorphoSys (1340243) Subject | Form SC 14D9/A | |
| 04/17/2024 3:30 PM | MorphoSys (1340243) Subject NOVARTIS AG (1114448) Filed by | Form SC TO-T/A | |
| 04/16/2024 4:07 PM | MorphoSys (1340243) Subject NOVARTIS AG (1114448) Filed by | Form SC TO-T/A | |
| 04/16/2024 9:12 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/15/2024 2:44 PM | MorphoSys (1340243) Subject NOVARTIS AG (1114448) Filed by | Form SC TO-T/A | |
| 04/12/2024 9:54 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/11/2024 10:57 AM | MorphoSys (1340243) Subject | Form SC 14D9 | |
| 04/11/2024 5:01 AM | MorphoSys (1340243) Subject NOVARTIS AG (1114448) Filed by | Form SC TO-T | |
| 04/09/2024 9:07 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/08/2024 9:19 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/04/2024 9:15 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Federal Reserve Reveals Disturbing New Plan To Control Your Money (Ad) Docket No. OP-1670 is drawing attention for what it reveals about the Federal Reserve's next move. Buried on page 84 is a plan that could expand oversight of checking accounts, purchases, and money transfers across the country.
Martin D. Weiss, PhD, founder of Weiss Ratings, breaks down what this document means and why it could roll out as soon as this summer. Watch the video to learn how this plan could affect you |
| 04/02/2024 9:08 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/27/2024 12:16 PM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/26/2024 10:15 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/25/2024 10:37 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/22/2024 10:17 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/22/2024 5:47 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/21/2024 10:27 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/20/2024 3:12 PM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/20/2024 10:13 AM | MorphoSys (1340243) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |